| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |